Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice

Life Sciences

Volumn 64, Issue 15, 1999, Pages 1339-1347

  Figueroa, Julio ^a   Vijayagopal, Parakat ^a   Debata, Chittaranjan ^a   Prasad, Anand ^a   Prasad, Chandan ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

AIDS; Azaftig; Cachexia; Cancer; Fat loss

Indexed keywords

AZAFTIG; FAT; PROTEIN; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANOREXIA; APPETITE; ARTICLE; BODY FAT; CACHEXIA; CANCER PATIENT; CONTROLLED STUDY; DRUG EFFECT; DRUG PURIFICATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; URINE; WEIGHT REDUCTION;

ANIMALIA;

EID: 0033525353     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00069-7     Document Type: Article

References (11)

1. G. O. Coodley, M. O. Loveless and T. M. Merrill. J. Acquir. Immune. Defic. Syndr. 7 681-694 (1994).
2. K. A. Nelson, D. Walsh and F. A. Sheehan. J. Clin. Oncol. 12 213-225 (1994).
3. C. Grunfeld and K. R. Feingold. N. Engl. J. Med. 327 329-337 (1992).
4. J. Figueroa, P. Vijayagopal, A. Prasad, D. V. Schapira and C. Prasad. AIDS Res. and Human Retrovir. (Under review) (1998)
5. T. P. Waalkes and S. Udenfriend. J. Lab. Clin. Med. 50 733-736 (1957)
6. H. P. Rodemann and A. L. Goldberg. J. Biol. Chem. 257 1632-1638 (1982).
7. J. Knoll. Biomed. Biochim. Acta 44 317-328 (1985).
8. A. M. Kidwai and R.K. Upretti. Molec. Cell. Biochem. 120 111-117 (1993).
9. T. M. McDevitt, P. T. Todorov, S. A. Beck, S. H. Khan and M. J. Tisdale. Cancer Res. 55 1458-1463 (1995).
10. P. T. Todorov, M. Deacon and M. J. Tisdale. J. Biol. Chem. 272 12279-12288 (1997).
11. P. Cariuk, M. J. Lorite, P. T. Todorov, W. N. Field, S. J. Wigmore and M. J. Tisdale. Brit. J. Cancer 76 606-613 (1997).